Sign in

CIK 0001062822

  • Non-accelerated filer
  • Smaller reporting company

LEXICON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
LXRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
760474169
Phone
+1 281-863-3000
Business address
2445 TECHNOLOGY FOREST BLVD., SUITE 1100, THE WOODLANDS, TX, 77381
Former names
LEXICON PHARMACEUTICALS, INC./DE, LEXICON GENETICS INC/TX
  1. 4 Shares withheld for taxes SVP, IR and Corp Comm gave up 74,572 shares (to pay taxes)
  2. 4 Shares withheld for taxes SVP, General Counsel & Secr. gave up 105,019 shares (to pay taxes)
  3. 4 Shares withheld for taxes SVP, Chief Financial Officer gave up 54,881 shares (to pay taxes)
  4. 4 Shares withheld for taxes Chief Executive Officer gave up 204,831 shares (to pay taxes)
  5. 4 Open-market buy Director bought 2,000 shares at $1.49 ($2,980)
  6. 4 Open-market buy Director bought 100,000 shares at $1.47 ($147,000)
  7. 4 Open-market buy Director bought 150,000 shares at an average $1.47 ($219,755)
  8. 4 Grant or award Director acquired 41,289.58 shares (grant or award)
  9. 4 Open-market buy Director bought 268,497 shares at an average $1.31 ($352,889)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market buy Director bought 1,538,462 shares at $1.30 ($2,000,001)
  20. 3 Insider Initial Statement of Ownership

Page 2 of 34 · 673 filings